These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11202055)

  • 1. Determination of porphobilinogen deaminase activity in human erythrocytes: pertinent factors in obtaining optimal conditions for measurements.
    Erlandsen EJ; Jørgensen PE; Markussen S; Brock A
    Scand J Clin Lab Invest; 2000 Nov; 60(7):627-34. PubMed ID: 11202055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
    Gross U; Jacob K; Frank M; Doss MO
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of hydroxymethylbilane synthase and uroporphyrinogen III synthase in erythrocytes by high-performance liquid chromatography.
    Wright DJ; Lim CK
    Biochem J; 1983 Jul; 213(1):85-8. PubMed ID: 6615434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.
    Gross U; Honcamp M; Doss MO
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):613-8. PubMed ID: 8877336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte porphobilinogen deaminase activity in porphyria cutanea tarda.
    Siersema PD; de Rooij FW; Edixhoven-Bosdijk A; Wilson JH
    Clin Chem; 1990 Oct; 36(10):1779-83. PubMed ID: 2208654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland.
    Mustajoki P; Kauppinen R; Lannfelt L; Lilius L; Koistinen J
    J Intern Med; 1992 Apr; 231(4):389-95. PubMed ID: 1588264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct assay of enzymes in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry. Porphobilinogen deaminase.
    Wang Y; Scott CR; Gelb MH; Turecek F
    Anal Chem; 2008 Apr; 80(7):2606-11. PubMed ID: 18294005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphobilinogen deaminase: methods and principles of the enzymatic assay.
    Anderson PM; Desnick RJ
    Enzyme; 1982; 28(2-3):146-57. PubMed ID: 7140717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
    Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
    Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte porphobilinogen deaminase activity and primary liver cancer.
    Kaczynski J; Hansson G; Thunell S; Wetterberg L; Wallerstedt S
    J Intern Med; 1995 Mar; 237(3):309-13. PubMed ID: 7891052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphobilinogen deaminase and uroporphyrinogen III synthase: structure, molecular biology, and mechanism.
    Shoolingin-Jordan PM
    J Bioenerg Biomembr; 1995 Apr; 27(2):181-95. PubMed ID: 7592565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.
    Johansson A; Möller C; Fogh J; Harper P
    Mol Med; 2003; 9(9-12):193-9. PubMed ID: 15208740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE; Ou CN; Ellefson RD
    Clin Chem; 1980 Jul; 26(8):1182-5. PubMed ID: 7389090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.
    Llewellyn DH; Whatley S; Elder GH
    Hum Mol Genet; 1993 Aug; 2(8):1315-6. PubMed ID: 8401516
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
    Mustajoki P
    Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.